Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,135 | 20 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $432.34 | 4 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $267.60 | 8 | $0 (2024) |
| Inari Medical, Inc. | $187.50 | 1 | $0 (2023) |
| BOSTON SCIENTIFIC CORPORATION | $120.11 | 2 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $71.95 | 2 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $21.06 | 1 | $0 (2022) |
| Gilead Sciences, Inc. | $19.73 | 1 | $0 (2021) |
| PFIZER INC. | $14.54 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $276.00 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($247.94) |
| 2023 | $187.50 | 1 | Inari Medical, Inc. ($187.50) |
| 2022 | $39.06 | 2 | E.R. Squibb & Sons, L.L.C. ($21.06) |
| 2021 | $119.60 | 4 | AstraZeneca Pharmaceuticals LP ($57.02) |
| 2019 | $290.05 | 6 | Janssen Pharmaceuticals, Inc ($178.69) |
| 2018 | $222.62 | 4 | BOSTON SCIENTIFIC CORPORATION ($120.11) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $123.44 | General |
| Category: DIABETES | ||||||
| 05/09/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $28.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.50 | General |
| Category: DIABETES | ||||||
| 05/24/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $187.50 | General |
| Category: VTE | ||||||
| 06/16/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.06 | General |
| Category: Cardiovascular | ||||||
| 05/24/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/07/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/03/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/08/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $57.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/21/2021 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: COVID-19 | ||||||
| 06/12/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/09/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/20/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/04/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $96.43 | General |
| Category: DIABETES | ||||||
| 02/13/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/05/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/05/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Food and Beverage | In-kind items and services | $87.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/01/2018 | BOSTON SCIENTIFIC CORPORATION | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $95.11 | General |
| Category: STRUCTURAL HEART | ||||||
| 10/15/2018 | BOSTON SCIENTIFIC CORPORATION | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: STRUCTURAL HEART | ||||||
| 09/28/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 184 | 216 | $62,740 | $19,026 |
| 2022 | 8 | 667 | 907 | $257,300 | $77,922 |
| 2021 | 9 | 574 | 742 | $252,825 | $78,784 |
| 2020 | 8 | 370 | 461 | $122,600 | $43,635 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 40 | 49 | $14,310 | $4,558 | 31.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 29 | 29 | $16,095 | $4,064 | 25.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 60 | $12,000 | $4,016 | 33.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 24 | 24 | $7,080 | $2,223 | 31.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $7,315 | $2,103 | 28.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 21 | 21 | $4,200 | $1,462 | 34.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 14 | $1,740 | $601.86 | 34.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 179 | 286 | $81,510 | $24,794 | 30.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 156 | 271 | $54,200 | $16,308 | 30.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 93 | 96 | $53,280 | $16,085 | 30.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 94 | 96 | $28,320 | $8,643 | 30.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 33 | 34 | $13,090 | $3,830 | 29.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 51 | 51 | $10,200 | $3,194 | 31.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 17 | 17 | $10,540 | $3,176 | 30.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 44 | 56 | $6,160 | $1,893 | 30.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 156 | 282 | $80,370 | $25,532 | 31.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 135 | 137 | $76,035 | $23,474 | 30.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 77 | 79 | $23,305 | $7,390 | 31.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 75 | 105 | $21,000 | $6,629 | 31.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 29 | 34 | $21,080 | $6,587 | 31.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 46 | 47 | $18,095 | $5,159 | 28.5% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 11 | 11 | $5,610 | $1,755 | 31.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 24 | 24 | $4,800 | $1,484 | 30.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 21 | 23 | $2,530 | $773.26 | 30.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 103 | 141 | $34,965 | $12,783 | 36.6% |
About Dr. Eduardo Pinto, M.D
Dr. Eduardo Pinto, M.D is a Internal Medicine healthcare provider based in Middletown, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013995620.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eduardo Pinto, M.D has received a total of $1,135 in payments from pharmaceutical and medical device companies, with $276.00 received in 2024. These payments were reported across 20 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,135).
As a Medicare-enrolled provider, Pinto has provided services to 1,795 Medicare beneficiaries, totaling 2,326 services with total Medicare billing of $219,367. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist
- Location Middletown, NY
- Active Since 01/04/2006
- Last Updated 10/13/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1013995620
Products in Payments
- JARDIANCE (Drug) $344.37
- XARELTO (Drug) $267.60
- FLOWTRIEVER CATHETER, S (Device) $187.50
- WATCHMAN (Device) $120.11
- PRADAXA (Drug) $87.97
- FARXIGA (Drug) $57.02
- CAMZYOS (Drug) $21.06
- Veklury (Drug) $19.73
- LOKELMA (Drug) $14.93
- CHANTIX (Drug) $14.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Middletown
Dr. Zainab Mogul-Ashraf, M.d, M.D
Internal Medicine — Payments: $190,519
Taraneh Soleymani, M.d, M.D
Internal Medicine — Payments: $165,396
Dr. John Ferguson, M.d, M.D
Internal Medicine — Payments: $22,796
Sabena Ramsetty
Internal Medicine — Payments: $19,117
Alexander Fruchter, Md, MD
Internal Medicine — Payments: $15,642
Dr. Angelo Paredes, M.d, M.D
Internal Medicine — Payments: $12,442